ProAssurance (PRA)
(Delayed Data from NYSE)
$13.91 USD
+0.34 (2.51%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $13.93 +0.02 (0.14%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.91 USD
+0.34 (2.51%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $13.93 +0.02 (0.14%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth B Momentum F VGM
Zacks News
First American (FAF) Rises 15% in 6 Months: Will the Rally Last?
by Zacks Equity Research
First American (FAF) remains well-poised to capitalize on the increased demand for first-time home purchases among millennials.
Chubb (CB) Rallies 37% in a Year: More Room for Upside?
by Zacks Equity Research
Chubb (CB) is set to grow on a compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and a solid capital position.
NMI Holdings (NMIH) Surges 29% YTD: Will the Rally Last?
by Zacks Equity Research
NMI Holdings (NMIH) is set to grow on an improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program and its solid capital position.
Arch Capital (ACGL) Rallies 32% YTD: More Room for Growth?
by Zacks Equity Research
Arch Capital (ACGL) continues to gain from business opportunities, rate increases, growth in existing accounts and a solid capital position.
Earnings Estimates Rising for ProAssurance (PRA): Will It Gain?
by Zacks Equity Research
ProAssurance (PRA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think ProAssurance (PRA) Could Surge 27.67%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.7% in ProAssurance (PRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ProAssurance (PRA) Q2 Earnings Beat, Surge Y/Y on Lower Costs
by Zacks Equity Research
ProAssurance's (PRA) Q2 results reflect strong underwriting results in the Specialty P&C segment and investment income growth, despite profitability pressures in some segments.
ProAssurance (PRA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for ProAssurance (PRA) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ProAssurance (PRA) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ProAssurance (PRA) delivered earnings and revenue surprises of 187.50% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Root, Inc. (ROOT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Root (ROOT) delivered earnings and revenue surprises of 70.11% and 25.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ProAssurance (PRA) Q2 Earnings: Profit Climb or Slippery Slope?
by Zacks Equity Research
ProAssurance's (PRA) second-quarter results are likely to reflect growing investment income.
ProAssurance (PRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for ProAssurance (PRA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Heritage Insurance (HRTG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Heritage Insurance (HRTG) delivered earnings and revenue surprises of 60.53% and 3.44%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Upbound Group (UPBD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Upbound Group (UPBD) delivered earnings and revenue surprises of 1.96% and 3.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ProAssurance (PRA) Moves 12.6% Higher: Will This Strength Last?
by Zacks Equity Research
ProAssurance (PRA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Here's Why Wait & See Style Is Apt for First American (FAF)
by Zacks Equity Research
First American (FAF) remains well-poised to capitalize on the increased demand for first-time home purchases among millennials.
AXIS Capital (AXS) Rises 30% YTD: What's Driving the Stock?
by Zacks Equity Research
AXIS Capital (AXS) continues to build on specialty insurance, reinsurance as well as the accident and health portfolio. An improved portfolio mix and effective capital deployment should drive growth.
Travelers (TRV) Rises 21% in a Year: More Room for Growth?
by Zacks Equity Research
Travelers (TRV) is set to gain from strong renewal rate change, solid retention, increase in new business supported by a compelling portfolio and a solid capital position.
Why You Should Stay Invested in Arch Capital (ACGL) Stock
by Zacks Equity Research
Arch Capital (ACGL) remains poised to gain from new business opportunities, rate improvement, favorable estimates and a solid capital position.
Unum (UNM) to Divest Medical Stop Loss Business to Amynta Group
by Zacks Equity Research
Unum's (UNM) decision to divest its Medical Stop Loss business to Amynta Group will help the insurer intensify its focus on its strategic growth priorities.
Here's Why You Should Retain Cincinnati Financial (CINF) Stock
by Zacks Equity Research
Cincinnati Financial (CINF) is set to grow on higher level of insured exposure, rate increase, agent-focused business model, consistent cash flow and a solid capital position.
Reasons Why Investors Should Consider Buying RLI Stock Now
by Zacks Equity Research
RLI stands to gain from a compelling product portfolio, rise in rate, improved retention, higher premium receipts, sufficient liquidity and effective capital deployment.
Here's Why You Should Stay Invested in Trupanion (TRUP) Stock
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on its focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position
Here's Why You Should Retain Hanover Insurance (THG) Stock
by Zacks Equity Research
Hanover Insurance (THG) stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.
Why Should You Stay Invested in Fidelity National (FNF) Stock?
by Zacks Equity Research
Fidelity National Financial (FNF) is set to grow from its market-leading position, higher direct premiums, agency premiums, strong origination demand and effective capital deployment.